CIPRIANI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 10.042
EU - Europa 8.939
AS - Asia 6.446
SA - Sud America 1.095
AF - Africa 157
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 11
Totale 26.717
Nazione #
US - Stati Uniti d'America 9.902
SG - Singapore 2.794
RU - Federazione Russa 2.747
GB - Regno Unito 2.380
CN - Cina 1.701
IT - Italia 1.111
BR - Brasile 875
VN - Vietnam 623
FR - Francia 598
HK - Hong Kong 577
FI - Finlandia 482
DE - Germania 481
IE - Irlanda 387
SE - Svezia 347
KR - Corea 219
UA - Ucraina 160
AR - Argentina 84
BD - Bangladesh 73
IN - India 73
CA - Canada 69
NL - Olanda 61
TR - Turchia 60
ID - Indonesia 54
NG - Nigeria 52
JP - Giappone 44
MX - Messico 43
IQ - Iraq 34
PK - Pakistan 33
EC - Ecuador 32
AT - Austria 28
ZA - Sudafrica 28
ES - Italia 26
AU - Australia 24
IL - Israele 23
PL - Polonia 23
PY - Paraguay 20
CO - Colombia 19
RO - Romania 19
BE - Belgio 18
UY - Uruguay 18
PH - Filippine 17
SA - Arabia Saudita 16
CL - Cile 14
PE - Perù 14
KE - Kenya 13
MA - Marocco 13
VE - Venezuela 13
AZ - Azerbaigian 12
JO - Giordania 12
EG - Egitto 11
CH - Svizzera 9
DZ - Algeria 9
EU - Europa 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
HU - Ungheria 8
TN - Tunisia 8
BG - Bulgaria 7
BY - Bielorussia 7
GR - Grecia 7
KZ - Kazakistan 7
LT - Lituania 6
CR - Costa Rica 5
HN - Honduras 5
IR - Iran 5
NP - Nepal 5
PT - Portogallo 5
AM - Armenia 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
KG - Kirghizistan 4
MY - Malesia 4
OM - Oman 4
QA - Qatar 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
TH - Thailandia 4
AL - Albania 3
AO - Angola 3
BN - Brunei Darussalam 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
LB - Libano 3
RS - Serbia 3
SI - Slovenia 3
UG - Uganda 3
BB - Barbados 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 26.693
Città #
Southend 2.103
Singapore 1.474
Jacksonville 1.299
Woodbridge 967
Chandler 841
San Jose 829
Ashburn 781
Moscow 738
Dallas 682
Ann Arbor 580
Hong Kong 569
Houston 555
Dublin 387
Verona 371
The Dalles 332
Beijing 278
Wilmington 222
Lawrence 216
Princeton 216
Ho Chi Minh City 202
New York 174
Nanjing 128
Hanoi 127
Los Angeles 124
Jinan 112
Milan 106
Buffalo 105
Shenyang 104
São Paulo 78
Hebei 73
Redondo Beach 61
Helsinki 58
Munich 58
Dong Ket 56
Tianjin 53
Changsha 49
Abuja 48
Rome 48
Sindelfingen 47
Nanchang 45
Santa Clara 45
Boardman 41
Council Bluffs 41
Haikou 40
Guangzhou 38
Hangzhou 38
Ningbo 36
Orem 35
Columbus 34
Washington 34
Tokyo 32
London 31
Norwalk 31
Dearborn 30
Redwood City 30
Zhengzhou 30
Taiyuan 29
Frankfurt am Main 28
Bologna 27
San Francisco 27
Jiaxing 26
Taizhou 25
Toronto 25
Manchester 24
Turku 24
Mexico City 22
Haiphong 21
Lancaster 21
Shanghai 21
Belo Horizonte 20
Chicago 20
Da Nang 19
Naples 19
Rio de Janeiro 19
Stockholm 19
Amsterdam 18
Brasília 18
Jakarta 17
Brooklyn 16
Chennai 16
Montevideo 16
Montreal 16
Barnet 15
Brussels 15
Florence 15
Fuzhou 15
Warsaw 15
Nuremberg 14
Vienna 14
Atlanta 13
Düsseldorf 13
Falls Church 13
Guayaquil 13
Johannesburg 13
Porto Alegre 13
Campinas 12
Curitiba 12
Dhaka 12
Lanzhou 12
Baghdad 11
Totale 16.655
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 583
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 406
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 305
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 245
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 229
Antidepressants and benzodiazepines for panic disorder in adults 215
Assessing risk of bias in randomized controlled trials 194
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 194
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 192
Azapirones versus placebo for panic disorder in adults 188
Allocation concealment and blinding in clinical trials 186
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 186
"Wish bias" in antidepressant drug trials? 184
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 182
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 182
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 181
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 180
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 180
Antidepressive Monotherapie 179
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 178
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 176
Sertraline versus other antidepressive agents for depression 174
Are all antidepressants really the same? The case of fluoxetine: a systematic review 170
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 170
Agomelatine and the brave old world of narrative-based medicine 170
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 166
Imputing missing standard deviations in meta-analyses can provide accurate results 166
Benzodiazepines and risk of dementia: true association or reverse causation? 165
What is a run-in phase? 163
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 161
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 161
Implementation of treatment guidelines for specialist mental health care 161
Citalopram versus other anti-depressive agents for depression. 160
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 159
A primer on network meta-analysis with emphasis on mental health 159
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 159
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 158
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 158
Antidepressants for Bipolar Disorder 157
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 157
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis 156
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 155
Citalopram versus other anti-depressive agents for depression 155
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis 155
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 153
Citalopram versus other anti-depressive agents for depression 153
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 152
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 151
Randomized trials published in Chinese or Western journals: comparative empirical analysis 149
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials 149
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development 149
Associazione tra TCA e SSRI nella depressione resistente 148
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 148
What is a systematic review? 148
Duloxetine versus other anti-depressive agents for depression 148
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 146
Implementation of treatment guidelines for specialist mental health care 143
Antidepressants in unipolar major depression: what we need to know 143
Seven criteria for improving effectiveness trials in psychiatry 142
Sertraline versus other antidepressive agents for depression 140
Levels of evidence: can quality of systematic reviews be quantified? 139
Advancing evidence-based practice to improve patient care 138
Outcome reporting bias in clinical trials 137
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 137
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 137
What is a risk ratio? 136
Paroxetine versus other anti-depressive agents for depression 135
Depressive disorders 134
What is a forest plot? 134
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 134
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 134
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 134
Implementation of treatment guidelines for specialist mental health care 134
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 133
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 133
Conventional vs. atypical antipsychotic medications [Letter] 129
Fluoxetine versus other types of pharmacotherapy for depression (Review) 129
Does the addiction of a second antipsychotic drug improve clozapine treatment? 129
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 129
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 127
Superiority, equivalence or non-inferiority? 126
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 125
What is a Cochrane review? 125
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 122
Escitalopram versus other antidepressive agents for depression 122
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 120
International dose differences in fluoxetine clinical trials conducted in patients with depression 120
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia 120
What is a clinical trial protocol? 120
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 119
Does randomised evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis 118
Validity of the impact factor of journals as a measure of randomised controlled trial quality 117
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis 117
What is a factorial trial? 117
Mirtazapine versus other antidepressive agents for depression 117
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 117
Conceptual and technical challenges in network meta-analysis 117
Olanzapine in long-term treatment for bipolar disorder. 116
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 114
Imputing response rates from means and standard deviations in meta-analyses 114
Totale 15.877
Categoria #
all - tutte 87.755
article - articoli 82.423
book - libri 373
conference - conferenze 0
curatela - curatele 0
other - altro 2.221
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.738
Totale 175.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 0 0 0 0 0 137 97
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20253.814 285 251 171 554 177 137 216 178 566 280 225 774
2025/20269.633 768 624 838 1.487 2.201 645 964 604 827 455 220 0
Totale 26.845